Key Takeaways:
• PACRA to be listed on PSX GEM board soon.
• Dividend policy announcement expected at the end of FY25.
• Enhanced earnings this quarter from CDC and NCCPL due to higher market volumes.
• New investments expected industrial gas and pharma sectors.
LSE Ventures Limited reported earnings per share of PKR 1.04 in FY24 against earnings per share of PKR 1.24 in FY23, a decrease of 16% Total revenue in FY24 reached PKR 286 Mn against PKR 127 Mn in FY23, an increase of 126%.
The company has a mandate of investing in cash flow positive businesses and as such has acquired stakes in Pakistan GasPort Consortium Limited and Berlitz Pakistan. Additionally, the company has two more investments of PKR 1 Bn each under consideration in the industrial gas and pharmaceutical sectors.
The management also informed that the PACRA transaction was under consideration with an aim of listing it on the PSX GEM board. It is expected that further developments in this regard will occur in January 2025.
Company management also clarified that the stakes in CDC and NCCPL were listed as held for sale due to SECP regulations however, there will be only be a sale when management believes the price is right. It was also revealed that the sale of these stakes can only be made to PSX or other institutions approved by SECP.
Going forward, the management was hopeful of enhanced earnings from CDC and NCCPL due to higher market volumes. In addition, it also revealed that at the end of FY25 it is hoped that a dividend payout policy will be put in place.
Important Disclosures
Disclaimer: This report has been prepared by Chase Securities Pakistan (Private) Limited and is provided for information purposes only. Under no circumstances, this is to be used or considered as an offer to sell or solicitation or any offer to buy. While reasonable care has been taken to ensure that the information contained in this report is not untrue or misleading at the time of its publication, Chase Securities makes no representation as to its accuracy or completeness and it should not be relied upon as such. From time to time, Chase Securities and/or any of its officers or directors may, as permitted by applicable laws, have a position, or otherwise be interested in any transaction, in any securities directly or indirectly subject of this report Chase Securities as a firm may have business relationships, including investment banking relationships with the companies referred to in this report This report is provided only for the information of professional advisers who are expected to make their own investment decisions without undue reliance on this report and Chase Securities accepts no responsibility whatsoever for any direct or indirect consequential loss arising from any use of this report or its contents At the same time, it should be noted that investments in capital markets are also subject to market risks This report may not be reproduced, distributed or published by any recipient for any purpose.
